News | March 20, 2023
Janssen announces novel dengue antiviral demonstrates efficacy in pre-clinical data
The antiviral is efficacious in non-human primates, and is safe and well-tolerated in humans
The antiviral is efficacious in non-human primates, and is safe and well-tolerated in humans
The Phase 3 data presented at AAD include a comprehensive review of the THRIVE-AA2 results and further elaborate the topline data reported in August 2022
This loan is in addition to earlier announced CAD 25 million loan committed by the Province of Quebec
Biocorp will receive an initial milestone payment this year
ALPLA is expanding its presence in the global market for pharmaceutical packaging by establishing a joint venture with Inden Pharma
Dr. Hubbard brings more than 35 years of experience in the biopharmaceutical and pharma-tech services industries and CROs.
Lupin Bioresearch Centre conducts BA/BE, PK/PD, In-vitro BE and biosimilar studies.
Open, scalable, end-to-end solution to improve diagnostic quality and efficiency
Company will invest in capacity increases, technological capabilities and long-term partnerships with key pharmaceutical and biotech companies
The inspection concluded with no observations
Subscribe To Our Newsletter & Stay Updated
